Journal
NEUROBIOLOGY OF AGING
Volume 34, Issue 12, Pages 2843-2852Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.06.003
Keywords
Amyloid; Alzheimer's disease; Microglia; CX3CR1; Hippocampus; Histone acetylation
Categories
Funding
- Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA
Ask authors/readers for more resources
The abnormal accumulation of amyloid fibrils in the brain is pathognomonic of Alzheimer's disease. Amyloid fibrils induce significant neuroinflammation characterized by the activation of microglia and impairment of synaptic plasticity in the brain that eventually leads to cognitive decline. Chemokine fractalkine receptor (CX3CR1) is primarily located in the microglia in the brain and its role in the amyloid fibril-induced neuroinflammation and memory deficiency remains debated. We found that bilateral microinjection of amyloid beta (A beta) 1-40 fibrils into the hippocampal CA1 area of rats resulted in significant upregulation of CX3CR1 messenger RNA (mRNA) and protein expression (via increasing histone H3 acetylation in the Cx3cr1 promoter region), synaptic dysfunction, and cognitive impairment, compared with the control group. Suppressing CX3CR1 signaling with CX3CR1 small interfering RNA in rats injected with A beta(1-40) fibrils blunted A beta(1-40)-induced CX3CR1 upregulation, microglial activation, interleukin-1 beta expression, restored basal glutamatergic strength and electric stimuli-induced long-term potentiation, and cognitive capacities. These findings suggest that activation of CX3CR1 plays an important role in the neuroinflammatory response and A beta-induced neuroinflammation and neurotoxicity. (C) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available